Evidence map›Paper›PMID 21280156›Full record

ArticleStem cells (Dayton, Ohio)2011

Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells.

Mingyao Ying, Yingying Sang, Yunqing Li, Hugo Guerrero-Cazares, Alfredo Quinones-Hinojosa, Angelo L Vescovi, Charles G Eberhart, Shuli Xia, John Laterra

Abstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Mingyao YingHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland 21205, USA.
Yingying Sang
Yunqing Li
Hugo Guerrero-Cazares
Alfredo Quinones-Hinojosa
Angelo L Vescovi
Charles G Eberhart
Shuli Xia
John Laterra
Johns Hopkins University · USJohns Hopkins Medicine · USKennedy Krieger Institute · USUniversity of Milano-Bicocca · IT

Funding

Mechanisms of Chemo/Radioresistance in Human GliomasR01NS043987 · NINDS · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI LATERRA, JOHN J, ROSEN, ELIOT M. · 2003 to 2012
$4.9M
Notch signaling in brain tumorsR01NS055089 · NINDS · JOHNS HOPKINS UNIVERSITY · PI EBERHART, CHARLES G · 2007 to 2016
$3.2M
Migration of Human Neural Stem Cells In Vitro and In VivoK08NS055851 · NINDS · JOHNS HOPKINS UNIVERSITY · PI QUINONES-HINOJOSA, ALFREDO · 2006 to 2010
$880k
NINDS NIH HHS 5K08 NS055851NINDS NIH HHS K08 NS055851NINDS NIH HHS R01 NS043987NINDS NIH HHS R01 NS055089NINDS NIH HHS R01 NS43987
6 · The paper itself

Abstract

Tumor-initiating stem cells (alternatively called cancer stem cells, CSCs) are a subpopulation of tumor cells that plays unique roles in tumor propagation, therapeutic resistance, and tumor recurrence. It is becoming increasingly important to understand the molecular signaling that regulates the self-renewal and differentiation of CSCs. Transcription factors are critical for the regulation of normal and neopolastic stem cells. Here, we examined the expression and function of the Krüppel-like family of transcription factors (KLFs) in human glioblastoma (GBM)-derived neurosphere lines and low-passage primary GBM-derived neurospheres that are enriched for tumor-initiating stem cells. We identify KLF9 as a relatively unique differentiation-induced transcription factor in GBM-derived neurospheres. KLF9 is shown to induce neurosphere cell differentiation, inhibit neurosphere formation, and inhibit neurosphere-derived xenograft growth in vivo. We also show that KLF9 regulates GBM neurosphere cells by binding to the Notch1 promoter and suppressing Notch1 expression and downstream signaling. Our results show for the first time that KLF9 has differentiating and tumor-suppressing functions in tumor-initiating stem cells.

Indexed as

Brain NeoplasmsCell DifferentiationCell LineGenes, Tumor SuppressorGenetic VectorsGlioblastomaHumansKruppel-Like Transcription FactorsNeoplastic Stem CellsReceptor, Notch1Signal TransductionTransduction, GeneticTransfectionKLF9 protein, humanKruppel-Like Transcription FactorsNOTCH1 protein, humanReceptor, Notch1

Identifiers

PMID21280156
PMCPMC3516843
OpenAlexW2065318299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.